Login / Signup

The Role of European Patient Organizations in Pharmacovigilance.

Cristiano MatosGerda WeitsFlorence van Hunsel
Published in: Drug safety (2020)
Bringing pharmacovigilance stakeholders and patient organizations together could create a more optimal reporting culture. Patient organizations appear to have an important role in encouraging patients to talk with their doctors/pharmacists about ADRs experienced, or to help him/her report the ADRs to the pharmacovigilance systems. Lack of resources, budget, and support from NCAs are seen as the main barriers to being involved in pharmacovigilance awareness.
Keyphrases
  • adverse drug
  • case report
  • drug induced
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • emergency department
  • primary care
  • electronic health record
  • patient reported